ON THE MOVE ...
Susan Boland has been named president of the division of Wheaton Franciscan Healthcare that includes the system’s All Saints Hospital in Racine, Wis., succeeding Ken Buser, who is retiring. Boland is senior VP and COO at All Saints and will assume Buser’s role as president of Wheaton Franciscan’s southern market when he retires in February 2013, according to a news release from the Glendale, Wis.-based system. Buser has worked for Wheaton Franciscan for 13 years, including overseeing expansions in cardiovascular and emergency care and advocating for an on-site daycare center, the release says. He served as a board member of the Wisconsin Hospital Association from 2001 to 2009, and was chairman of the board in 2008. Boland, who has worked in executive roles with other systems, became VP of patient care at All Saints starting in 1995. She was promoted to COO in 2005. ... Marin General Hospital, Greenbrae, Calif., has named
Mark Zielazinski chief information and technology integration officer. Since 2010, Zielazinski, whose age wasn’t provided, had served as CIO at Alameda County Medical Center, Oakland, Calif. Soma Bulusu will continue as VP of IT at Marin General and will report to Zielazinski. Marin General CEO Lee Domanico worked with Zielazinski at El Camino Hospital, Mountain View, Calif., where Zielazinski served as CIO from 2001 to 2006. ... Cleveland Clinic has lifted the interim tag off the title of and made
Kelly Hancock her the system’s executive chief nursing officer. Hancock, whose age wasn’t provided, had served in an interim capacity since April. She had served as CNO for Cleveland Clinic’s main campus and will keep those duties while assuming her new role. Sarah Sinclair served as executive CNO officer before Hancock. Hancock’s duties include leading the 11,000 nurses at Cleveland Clinic’s Zlelony Institute for Nursing Excellence, which oversees nurse practice and education at the system.
AstraZeneca, a London-based drugmaker, tapped Roche executive as CEO. Soriot, 53, has served as Pascal Soriot COO for Roche’s pharmaceuticals division since 2010 and is a former CEO of Genentech, which Roche acquired in 2009. He will replace David Brennan, who said in April that he planned to retire. Simon Lowth, AstraZeneca’s CFO, will continue to serve as interim CEO until Soriot’s start date in October. … St. Paul, Minn.-based medical devicemaker St. Jude Medical said it restructured its product divisions into two operating units and named Dr. Eric Fain Frank Callaghan and as the units’ leaders. Fain is now president of the implantable-electronic systems division, which is made up of St. Jude’s former cardiac rhythm-management and neuro-modulation divisions, according to a news release. He previously served as president of the cardiac rhythm-management division. Callaghan will oversee the cardiovascular and ablation technologies division, which includes the former atrial fibrillation and cardiovascular divisions. He has served as president of the cardiovascular division since 2008. Ages for Fain and Callaghan were not available. “The reorganization we have announced today is part of a comprehensive plan to accelerate our growth,” said Daniel Starks, St. Jude’s chairman, president and CEO, in the news release. The company also said it had eliminated the jobs of 300 employees in the restructuring. Earlier this year, St. Jude announced plans to consolidate its cardiovascular division operations in Plymouth, Minn.
Mark Henke, who became president and CEO of Northfield (Minn.) Hospital & Clinics in April 2010, died Aug. 31 while undergoing surgery for renal cancer. He was 53. A statement from the city-owned hospital said Henke was known as a strategic thinker and creative problem-solver who initiated expansions of the Cancer Care and Infusion Center and oversaw the opening of a new primary-care clinic in the city of Elko New Market, Minn. Henke is survived by his wife Joyce and five children.